Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Aymes powder 2.3 - 2.4 kcal/ml milkshake lower volume
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aymes Shake Compact powder 57g sachets banana
0913011F0BBAAAA
|
Aymes powder 2.3 - 2.4 kcal/ml milkshake lower volume | Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 5,915 |
|
Aymes Shake Compact powder 57g sachets strawberry
0913011F0BBAEAA
|
Aymes powder 2.3 - 2.4 kcal/ml milkshake lower volume | Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 4,040 |
|
Aymes Shake Compact powder 57g sachets vanilla
0913011F0BBAFAA
|
Aymes powder 2.3 - 2.4 kcal/ml milkshake lower volume | Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 3,615 |
|
Aymes Shake Compact powder 57g sachets chocolate
0913011F0BBABAA
|
Aymes powder 2.3 - 2.4 kcal/ml milkshake lower volume | Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 2,611 |
|
Aymes Shake Compact powder 57g sachets neutral
0913011F0BBADAA
|
Aymes powder 2.3 - 2.4 kcal/ml milkshake lower volume | Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 1,333 |
|
Aymes Shake Compact powder 57g sachets ginger
0913011F0BBACAA
|
Aymes powder 2.3 - 2.4 kcal/ml milkshake lower volume | Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 661 |
|
Aymes Shake Compact Starter Pack powder
0913011F0BBAGAB
|
Aymes powder 2.3 - 2.4 kcal/ml milkshake lower volume | Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 366 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.